Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases—a Japanese Nationwide Survey
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-019-04250-9
Abstract: Background The survival benefit of and indications for adjuvant chemotherapy (AC) for colorectal liver metastases (CRLM) remain unclear. Methods Patients who were diagnosed with liver-limited CRLM between 2005 and 2007 and subsequently underwent R0 resection… read more here.
Keywords: chemotherapy; survival benefit; adjuvant chemotherapy; benefit indications ... See more keywords